Notch increases the shedding of HB-EGF by ADAM12 to potentiate invadopodia formation in hypoxia

Journal of Cell Biology

Volumn 201, Issue 2, 2013, Pages 279-292

  Díaz, Begoña ^a   Yuen, Angela ^a   Iizuka, Shinji ^a   Higashiyama, Shigeki ^b   Courtneidge, Sara A ^a  

^a BURNHAM INSTITUTE   (United States)

^b EHIME UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; ADAM12 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NOTCH RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER INVASION; CELL COMMUNICATION; CELL CONTACT; CELL HYPOXIA; CELL INVASION; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM TUMOR; HUMAN; HUMAN CELL; INVADOPODIUM; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION;

ADAM PROTEINS; CELL COMMUNICATION; CELL HYPOXIA; CELL LINE, TUMOR; EPITHELIAL CELLS; EPITHELIUM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; PROTEIN STRUCTURE, TERTIARY; PSEUDOPODIA; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

EID: 84876705197     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201209151     Document Type: Article

References (102)

1. Abram, C.L., D.F. Seals, I. Pass, D. Salinsky, L. Maurer, T.M. Roth, and S.A. Courtneidge. 2003. The adaptor protein fish associates with members of the ADAMs family and localizes to podosomes of Src-transformed cells. J. Biol. Chem. 278:16844-16851. http://dx.doi.org/10.1074/jbc.M300267200
2. Adelman, D.M., M. Gertsenstein, A. Nagy, M.C. Simon, and E. Maltepe. 2000. Placental cell fates are regulated in vivo by HIF-mediated hypoxia responses. Genes Dev. 14:3191-3203. http://dx.doi.org/10.1101/gad.853700
3. Agrawal, N., M.J. Frederick, C.R. Pickering, C. Bettegowda, K. Chang, R.J. Li, C. Fakhry, T.X. Xie, J. Zhang, J. Wang, et al. 2011. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 333:1154-1157. http://dx.doi.org/10.1126/science.1206923
4. Albrechtsen, R., D. Stautz, A. Sanjay, M. Kveiborg, and U.M. Wewer. 2011. Extracellular engagement of ADAM12 induces clusters of invadopodia with localized ectodomain shedding activity. Exp. Cell Res. 317:195-209. http://dx.doi.org/10.1016/j.yexcr.2010.10.003
5. Amarilio, R., S.V. Viukov, A. Sharir, I. Eshkar-Oren, R.S. Johnson, and E. Zelzer. 2007. HIF1alpha regulation of Sox9 is necessary to maintain differentiation of hypoxic prechondrogenic cells during early skeletogenesis. Development. 134:3917-3928. http://dx.doi.org/10.1242/dev.008441
6. Asakura M., M. Kitakaze, S. Takashima, Y. Liao, F. Ishikura, T. Yoshinaka, H. Ohmoto, K. Node, K. Yoshino, H. Ishiguro, et al. 2002. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat. Med. 8:35-40. http://dx.doi.org/10.1038/nm0102-35
7. Bedogni, B., J.A. Warneke, B.J. Nickoloff, A.J. Giaccia, and M.B. Powell. 2008. Notch1 is an effector of Akt and hypoxia in melanoma development. J. Clin. Invest. 118:3660-3670. http://dx.doi.org/10.1172/JCI36157
8. Bhattacharjee, A., W.G. Richards, J. Staunton, C. Li, S. Monti, P. Vasa, C. Ladd, J. Beheshti, R. Bueno, M. Gillette, et al. 2001. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. USA. 98:13790-13795. http://dx.doi.org/10.1073/pnas.191502998
9. Bos, P.D., X.H. Zhang, C. Nadal, W. Shu, R.R. Gomis, D.X. Nguyen, A.J. Minn, M.J. van de Vijver, W.L. Gerald, J.A. Foekens, and J. Massagué. 2009. Genes that mediate breast cancer metastasis to the brain. Nature. 459:1005-1009. http://dx.doi.org/10.1038/nature08021
10. Bravo-Cordero, J.J., L. Hodgson, and J. Condeelis. 2012. Directed cell invasion and migration during metastasis. Curr. Opin. Cell Biol. 24:277-283. http://dx.doi.org/10.1016/j.ceb.2011.12.004
11. Brizel, D.M., S.P. Scully, J.M. Harrelson, L.J. Layfield, J.M. Bean, L.R. Prosnitz, and M.W. Dewhirst. 1996. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56:941-943.
12. Brou, C., F. Logeat, N. Gupta, C. Bessia, O. LeBail, J.R. Doedens, A. Cumano, P. Roux, R.A. Black, and A. Israël. 2000. A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol. Cell. 5:207-216. http://dx.doi.org/10.1016/S1097-2765(00)80417-7
13. Burgstaller, G., and M. Gimona. 2005. Podosome-mediated matrix resorption and cell motility in vascular smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 288:H3001-H3005. http://dx.doi.org/10.1152/ajpheart.01002.2004
14. Chen, C., N. Pore, A. Behrooz, F. Ismail-Beigi, and A. Maity. 2001. Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia. J. Biol. Chem. 276:9519-9525. http://dx.doi.org/10.1074/jbc.M010144200
15. Chen, J., N. Imanaka, J. Chen, and J.D. Griffin. 2010. Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion. Br. J. Cancer. 102:351-360. http://dx.doi.org/10.1038/sj.bjc.6605486
16. Chen, W.T. 1989. Proteolytic activity of specialized surface protrusions formed at rosette contact sites of transformed cells. J. Exp. Zool. 251:167-185. http://dx.doi.org/10.1002/jez.1402510206
17. Chen, Y., M.A. De Marco, I. Graziani, A.F. Gazdar, P.R. Strack, L. Miele, and M. Bocchetta. 2007. Oxygen concentration determines the biological effects of NOTCH-1 signaling in adenocarcinoma of the lung. Cancer Res. 67:7954-7959. http://dx.doi.org/10.1158/0008-5472.CAN-07-1229
18. Clark, E.S., A.S. Whigham, W.G. Yarbrough, and A.M. Weaver. 2007. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res. 67:4227-4235. http://dx.doi.org/10.1158/0008-5472.CAN-06-3928
19. Compernolle, V., K. Brusselmans, D. Franco, A. Moorman, M. Dewerchin, D. Collen, and P. Carmeliet. 2003. Cardia bifida, defective heart development and abnormal neural crest migration in embryos lacking hypoxiainducible factor-1alpha. Cardiovasc. Res. 60:569-579. http://dx.doi.org/10.1016/j.cardiores.2003.07.003
20. Dateoka, S., Y. Ohnishi, and K. Kakudo. 2012. Effects of CRM197, a specific inhibitor of HB-EGF, in oral cancer. Med. Mol. Morphol. 45:91-97. http://dx.doi.org/10.1007/s00795-011-0543-6
21. De Strooper, B., W. Annaert, P. Cupers, P. Saftig, K. Craessaerts, J.S. Mumm, E.H. Schroeter, V. Schrijvers, M.S. Wolfe, W.J. Ray, et al. 1999. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature. 398:518-522. http://dx.doi.org/10.1038/19083
22. Eckert, M.A., T.M. Lwin, A.T. Chang, J. Kim, E. Danis, L. Ohno-Machado, and J. Yang. 2011. Twist1-induced invadopodia formation promotes tumor metastasis. Cancer Cell. 19:372-386. http://dx.doi.org/10.1016/j.ccr.2011.01.036
23. Ellisen, L.W., J. Bird, D.C. West, A.L. Soreng, T.C. Reynolds, S.D. Smith, and J. Sklar. 1991. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell. 66:649-661. http://dx.doi.org/10.1016/0092-8674(91)90111-B
24. Friedl, P., J. Locker, E. Sahai, and J.E. Segall. 2012. Classifying collective cancer cell invasion. Nat. Cell Biol. 14:777-783. http://dx.doi.org/10.1038/ncb2548
25. Fröhlich, C., R. Albrechtsen, L. Dyrskjøt, L. Rudkjaer, T.F. ørntoft, and U.M. Wewer. 2006. Molecular profiling of ADAM12 in human bladder cancer. Clin. Cancer Res. 12:7359-7368. http://dx.doi.org/10.1158/1078-0432.CCR-06-1066
26. Garber, M.E., O.G. Troyanskaya, K. Schluens, S. Petersen, Z. Thaesler, M. Pacyna-Gengelbach, M. van de Rijn, G.D. Rosen, C.M. Perou, R.I. Whyte, et al. 2001. Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. USA. 98:13784-13789. http://dx.doi.org/10.1073/pnas.241500798
27. Goishi, K., S. Higashiyama, M. Klagsbrun, N. Nakano, T. Umata, M. Ishikawa, E. Mekada, and N. Taniguchi. 1995. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. Mol. Biol. Cell. 6:967-980.
28. Guruharsha, K.G., M.W. Kankel, and S. Artavanis-Tsakonas. 2012. The Notch signalling system: recent insights into the complexity of a conserved pathway. Nat. Rev. Genet. 13:654-666. http://dx.doi.org/10.1038/nrg3272
29. Gustafsson, M.V., X. Zheng, T. Pereira, K. Gradin, S. Jin, J. Lundkvist, J.L. Ruas, L. Poellinger, U. Lendahl, and M. Bondesson. 2005. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev. Cell. 9:617-628. http://dx.doi.org/10.1016/j.devcel.2005.09.010
30. Hanahan, D., and R.A. Weinberg. 2011. Hallmarks of cancer: the next generation. Cell. 144:646-674. http://dx.doi.org/10.1016/j.cell.2011.02.013
31. Higashiyama, S., J.A. Abraham, J. Miller, J.C. Fiddes, and M. Klagsbrun. 1991. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science. 251:936-939. http://dx.doi.org/10.1126/science.1840698
32. Higashiyama, S., R. Iwamoto, K. Goishi, G. Raab, N. Taniguchi, M. Klagsbrun, and E. Mekada. 1995. The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparinbinding EGF-like growth factor. J. Cell Biol. 128:929-938. http://dx.doi.org/10.1083/jcb.128.5.929
33. Hiraga, T., S. Kizaka-Kondoh, K. Hirota, M. Hiraoka, and T. Yoneda. 2007. Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer. Cancer Res. 67:4157-4163. http://dx.doi.org/10.1158/0008-5472.CAN-06-2355
34. Höckel, M., K. Schlenger, C. Knoop, and P. Vaupel. 1991. Oxygenation of carcinomas of the uterine cervix: evaluation by computerized O2 tension measurements. Cancer Res. 51:6098-6102.
35. Höckel, M., K. Schlenger, B. Aral, M. Mitze, U. Schaffer, and P. Vaupel. 1996. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56:4509-4515.
36. Hou, J., J. Aerts, B. den Hamer, W. van Ijcken, M. den Bakker, P. Riegman, C. van der Leest, P. van der Spek, J.A. Foekens, H.C. Hoogsteden, et al. 2010. Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS ONE. 5:e10312. http://dx.doi.org/10.1371/journal.pone.0010312
37. Hu, B., E. Castillo, L. Harewood, P. Ostano, A. Reymond, R. Dummer, W. Raffoul, W. Hoetzenecker, G.F. Hofbauer, and G.P. Dotto. 2012. Multifocal epithelial tumors and field cancerization from loss of mesenchymal CSL signaling. Cell. 149:1207-1220. http://dx.doi.org/10.1016/j.cell.2012.03.048
38. Keith, B., and M.C. Simon. 2007. Hypoxia-inducible factors, stem cells, and cancer. Cell. 129:465-472. http://dx.doi.org/10.1016/j.cell.2007.04.019
39. Kodama, T., E. Ikeda, A. Okada, T. Ohtsuka, M. Shimoda, T. Shiomi, K. Yoshida, M. Nakada, E. Ohuchi, and Y. Okada. 2004. ADAM12 is selectively overexpressed in human glioblastomas and is associated with glioblastoma cell proliferation and shedding of heparin-binding epidermal growth factor. Am. J. Pathol. 165:1743-1753. http://dx.doi.org/10.1016/S0002-9440(10)63429-3
40. Krishnan, J., P. Ahuja, S. Bodenmann, D. Knapik, E. Perriard, W. Krek, and J.C. Perriard. 2008. Essential role of developmentally activated hypoxiainducible factor 1alpha for cardiac morphogenesis and function. Circ. Res. 103:1139-1146. http://dx.doi.org/10.1161/01.RES.0000338613.89841.c1
41. Kung, A.L., S. Wang, J.M. Klco, W.G. Kaelin, and D.M. Livingston. 2000. Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat. Med. 6:1335-1340. http://dx.doi.org/10.1038/82146
42. Kurisaki, T., A. Masuda, K. Sudo, J. Sakagami, S. Higashiyama, Y. Matsuda, A. Nagabukuro, A. Tsuji, Y. Nabeshima, M. Asano, et al. 2003. Phenotypic analysis of Meltrin alpha (ADAM12)-deficient mice: involvement of Meltrin alpha in adipogenesis and myogenesis. Mol. Cell. Biol. 23:55-61. http://dx.doi.org/10.1128/MCB.23.1.55-61.2003
43. Kveiborg, M., C. Fröhlich, R. Albrechtsen, V. Tischler, N. Dietrich, P. Holck, P. Kronqvist, F. Rank, A.M. Mercurio, and U.M. Wewer. 2005. A role for ADAM12 in breast tumor progression and stromal cell apoptosis. Cancer Res. 65:4754-4761. http://dx.doi.org/10.1158/0008-5472.CAN-05-0262
44. Landi, M.T., T. Dracheva, M. Rotunno, J.D. Figueroa, H. Liu, A. Dasgupta, F.E. Mann, J. Fukuoka, M. Hames, A.W. Bergen, et al. 2008. Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival. PLoS ONE. 3:e1651. http://dx.doi.org/10.1371/journal.pone.0001651
45. Lendeckel, U., J. Kohl, M. Arndt, S. Carl-McGrath, H. Donat, and C. Röcken. 2005. Increased expression of ADAM family members in human breast cancer and breast cancer cell lines. J. Cancer Res. Clin. Oncol. 131:41-48. http://dx.doi.org/10.1007/s00432-004-0619-y
46. Le Pabic, H., D. Bonnier, U.M. Wewer, A. Coutand, O. Musso, G. Baffet, B. Clément, and N. Théret. 2003. ADAM12 in human liver cancers: TGF-beta-regulated expression in stellate cells is associated with matrix remodeling. Hepatology. 37:1056-1066. http://dx.doi.org/10.1053/jhep.2003.50205
47. Lester, R.D., M. Jo, V. Montel, S. Takimoto, and S.L. Gonias. 2007. uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells. J. Cell Biol. 178:425-436. http://dx.doi.org/10.1083/jcb.200701092
48. Li, H., E. Solomon, S. Duhachek Muggy, D. Sun, and A. Zolkiewska. 2011. Metalloprotease-disintegrin ADAM12 expression is regulated by Notch signaling via microRNA-29. J. Biol. Chem. 286:21500-21510. http://dx.doi.org/10.1074/jbc.M110.207951
49. Liao, D., C. Corle, T.N. Seagroves, and R.S. Johnson. 2007. Hypoxia-inducible factor-1alpha is a key regulator of metastasis in a transgenic model of cancer initiation and progression. Cancer Res. 67:563-572. http://dx.doi.org/10.1158/0008-5472.CAN-06-2701
50. Linder, S. 2007. The matrix corroded: podosomes and invadopodia in extracellular matrix degradation. Trends Cell Biol. 17:107-117. http://dx.doi.org/10.1016/j.tcb.2007.01.002
51. Linder, S., D. Nelson, M. Weiss, and M. Aepfelbacher. 1999. Wiskott-Aldrich syndrome protein regulates podosomes in primary human macrophages. Proc. Natl. Acad. Sci. USA. 96:9648-9653. http://dx.doi.org/10.1073/pnas.96.17.9648
52. Lucien, F., K. Brochu-Gaudreau, D. Arsenault, K. Harper, and C.M. Dubois. 2011. Hypoxia-induced invadopodia formation involves activation of NHE-1 by the p90 ribosomal S6 kinase (p90RSK). PLoS ONE. 6:e28851. http://dx.doi.org/10.1371/journal.pone.0028851
53. Maraver, A., P.J. Fernandez-Marcos, D. Herranz, M. Cañamero, M. Muñoz-Martin, G. Gómez-López, F. Mulero, D. Megías, M. Sanchez-Carbayo, J. Shen, et al. 2012. Therapeutic effect of ?-secretase inhibition in KrasG12V-driven non-small cell lung carcinoma by derepression of DUSP1 and inhibition of ERK. Cancer Cell. 22:222-234. http://dx.doi.org/10.1016/j.ccr.2012.06.014
54. Marchisio, P.C., D. Cirillo, L. Naldini, M.V. Primavera, A. Teti, and A. Zambonin-Zallone. 1984. Cell-substratum interaction of cultured avian osteoclasts is mediated by specific adhesion structures. J. Cell Biol. 99: 1696-1705. http://dx.doi.org/10.1083/jcb.99.5.1696
55. Markowski, J., M. Oczko-Wojciechowska, T. Gierek, M. Jarzab, J. Paluch, M. Kowalska, Z. Wygoda, A. Pfeifer, T. Tyszkiewicz, B. Jarzab, et al. 2009. Gene expression profile analysis in laryngeal cancer by high-density oligonucleotide microarrays. J. Physiol. Pharmacol. 60(Suppl. 1):57-63.
56. Maxwell, P.H., G.U. Dachs, J.M. Gleadle, L.G. Nicholls, A.L. Harris, I.J. Stratford, O. Hankinson, C.W. Pugh, and P.J. Ratcliffe. 1997. Hypoxiainducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl. Acad. Sci. USA. 94:8104-8109. http://dx.doi.org/10.1073/pnas.94.15.8104
57. Mazure, N.M., E.Y. Chen, P. Yeh, K.R. Laderoute, and A.J. Giaccia. 1996. Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression. Cancer Res. 56:3436-3440.
58. Mino, N., R. Miyahara, E. Nakayama, T. Takahashi, A. Takahashi, S. Iwakiri, M. Sonobe, K. Okubo, T. Hirata, A. Sehara, and H. Date. 2009. A disintegrin and metalloprotease 12 (ADAM12) is a prognostic factor in resected pathological stage I lung adenocarcinoma. J. Surg. Oncol. 100:267-272. http://dx.doi.org/10.1002/jso.21313
59. Mitamura, T., S. Higashiyama, N. Taniguchi, M. Klagsbrun, and E. Mekada. 1995. Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity. J. Biol. Chem. 270:1015-1019. http://dx.doi.org/10.1074/jbc.270.3.1015
60. Miyamoto, S., M. Hirata, A. Yamazaki, T. Kageyama, H. Hasuwa, H. Mizushima, Y. Tanaka, H. Yagi, K. Sonoda, M. Kai, et al. 2004. Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy. Cancer Res. 64:5720-5727. http://dx.doi.org/10.1158/0008-5472.CAN-04-0811
61. Mumm, J.S., E.H. Schroeter, M.T. Saxena, A. Griesemer, X. Tian, D.J. Pan, W.J. Ray, and R. Kopan. 2000. A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol. Cell. 5:197-206. http://dx.doi.org/10.1016/S1097-2765(00)80416-5
62. Murphy, D.A., and S.A. Courtneidge. 2011. The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function. Nat. Rev. Mol. Cell Biol. 12:413-426. http://dx.doi.org/10.1038/nrm3141
63. Murphy, D.A., B. Diaz, P.A. Bromann, J.H. Tsai, Y. Kawakami, J. Maurer, R.A. Stewart, J.C. Izpisúa-Belmonte, and S.A. Courtneidge. 2011. A Src-Tks5 pathway is required for neural crest cell migration during embryonic development. PLoS ONE. 6:e22499. http://dx.doi.org/10.1371/journal.pone.0022499
64. Ohh, M., C.W. Park, M. Ivan, M.A. Hoffman, T.Y. Kim, L.E. Huang, N. Pavletich, V. Chau, and W.G. Kaelin. 2000. Ubiquitination of hypoxiainducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat. Cell Biol. 2:423-427. http://dx.doi.org/10.1038/35017054
65. Ongusaha, P.P., J.C. Kwak, A.J. Zwible, S. Macip, S. Higashiyama, N. Taniguchi, L. Fang, and S.W. Lee. 2004. HB-EGF is a potent inducer of tumor growth and angiogenesis. Cancer Res. 64:5283-5290. http://dx.doi.org/10.1158/0008-5472.CAN-04-0925
66. Peduto, L., V.E. Reuter, A. Sehara-Fujisawa, D.R. Shaffer, H.I. Scher, and C.P. Blobel. 2006. ADAM12 is highly expressed in carcinoma-associated stroma and is required for mouse prostate tumor progression. Oncogene. 25:5462-5466. http://dx.doi.org/10.1038/sj.onc.1209536
67. Petcherski, A.G., and J. Kimble. 2000. Mastermind is a putative activator for Notch. Curr. Biol. 10:R471-R473. http://dx.doi.org/10.1016/S0960-9822(00)00577-7
68. Provot, S., D. Zinyk, Y. Gunes, R. Kathri, Q. Le, H.M. Kronenberg, R.S. Johnson, M.T. Longaker, A.J. Giaccia, and E. Schipani. 2007. Hif-1α regulates differentiation of limb bud mesenchyme and joint development. J. Cell Biol. 177:451-464. http://dx.doi.org/10.1083/jcb.200612023
69. Rocks, N., G. Paulissen, F. Quesada Calvo, M. Polette, M. Gueders, C. Munaut, J.M. Foidart, A. Noel, P. Birembaut, and D. Cataldo. 2006. Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC). Br. J. Cancer. 94:724-730.
70. Roepman, P., L.F. Wessels, N. Kettelarij, P. Kemmeren, A.J. Miles, P. Lijnzaad, M.G. Tilanus, R. Koole, G.J. Hordijk, P.C. van der Vliet, et al. 2005. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat. Genet. 37:182-186. http://dx.doi.org/10.1038/ng1502
71. Roy, R., S. Rodig, D. Bielenberg, D. Zurakowski, and M.A. Moses. 2011. ADAM12 transmembrane and secreted isoforms promote breast tumor growth: a distinct role for ADAM12-S protein in tumor metastasis. J. Biol. Chem. 286:20758-20768. http://dx.doi.org/10.1074/jbc.M110.216036
72. Rubin, J.S., A.M. Chan, D.P. Bottaro, W.H. Burgess, W.G. Taylor, A.C. Cech, D.W. Hirschfield, J. Wong, T. Miki, P.W. Finch, et al. 1991. A broadspectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc. Natl. Acad. Sci. USA. 88:415-419. http://dx.doi.org/10.1073/pnas.88.2.415
73. Sahin, U., G. Weskamp, K. Kelly, H.M. Zhou, S. Higashiyama, J. Peschon, D. Hartmann, P. Saftig, and C.P. Blobel. 2004. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J. Cell Biol. 164:769-779. http://dx.doi.org/10.1083/jcb.200307137
74. Sahlgren, C., M.V. Gustafsson, S. Jin, L. Poellinger, and U. Lendahl. 2008. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc. Natl. Acad. Sci. USA. 105:6392-6397. http://dx.doi.org/10.1073/pnas.0802047105
75. Santagata, S., F. Demichelis, A. Riva, S. Varambally, M.D. Hofer, J.L. Kutok, R. Kim, J. Tang, J.E. Montie, A.M. Chinnaiyan, et al. 2004. JAGGED1 expression is associated with prostate cancer metastasis and recurrence. Cancer Res. 64:6854-6857. http://dx.doi.org/10.1158/0008-5472.CAN-04-2500
76. Seals, D.F., and S.A. Courtneidge. 2003. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev. 17:7-30. http://dx.doi.org/10.1101/gad.1039703
77. Seals, D.F., E.F. Azucena Jr., I. Pass, L. Tesfay, R. Gordon, M. Woodrow, J.H. Resau, and S.A. Courtneidge. 2005. The adaptor protein Tks5/Fish is required for podosome formation and function, and for the proteasedriven invasion of cancer cells. Cancer Cell. 7:155-165. http://dx.doi.org/10.1016/j.ccr.2005.01.006
78. Sethi, N., X. Dai, C.G. Winter, and Y. Kang. 2011. Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. Cancer Cell. 19:192-205. http://dx.doi.org/10.1016/j.ccr.2010.12.022
79. Sjöblom, T., S. Jones, L.D. Wood, D.W. Parsons, J. Lin, T.D. Barber, D. Mandelker, R.J. Leary, J. Ptak, N. Silliman, et al. 2006. The consensus coding sequences of human breast and colorectal cancers. Science. 314:268-274. http://dx.doi.org/10.1126/science.1133427
80. Stautz, D., A. Sanjay, M.T. Hansen, R. Albrechtsen, U.M. Wewer, and M. Kveiborg. 2010. ADAM12 localizes with c-Src to actin-rich structures at the cell periphery and regulates Src kinase activity. Exp. Cell Res. 316:55-67. http://dx.doi.org/10.1016/j.yexcr.2009.09.017
81. Stearman, R.S., L. Dwyer-Nield, L. Zerbe, S.A. Blaine, Z. Chan, P.A. Bunn Jr., G.L. Johnson, F.R. Hirsch, D.T. Merrick, W.A. Franklin, et al. 2005. Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model. Am. J. Pathol. 167:1763-1775. http://dx.doi.org/10.1016/S0002-9440(10)61257-6
82. Stransky, N., A.M. Egloff, A.D. Tward, A.D. Kostic, K. Cibulskis, A. Sivachenko, G.V. Kryukov, M.S. Lawrence, C. Sougnez, A. McKenna, et al. 2011. The mutational landscape of head and neck squamous cell carcinoma. Science. 333:1157-1160. http://dx.doi.org/10.1126/science.1208130
83. Su, L.J., C.W. Chang, Y.C. Wu, K.C. Chen, C.J. Lin, S.C. Liang, C.H. Lin, J. Whang-Peng, S.L. Hsu, C.H. Chen, and C.Y. Huang. 2007. Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme. BMC Genomics. 8:140. http://dx.doi.org/10.1186/1471-2164-8-140
84. Talbot, S.G., C. Estilo, E. Maghami, I.S. Sarkaria, D.K. Pham, P. O-charoenrat, N.D. Socci, I. Ngai, D. Carlson, R. Ghossein, et al. 2005. Gene expression profiling allows distinction between primary and metastatic squamous cell carcinomas in the lung. Cancer Res. 65:3063-3071.
85. Tang, X.H., S. Deng, M. Li, and M.S. Lu. 2012. The anti-tumor effect of cross-reacting material 197, an inhibitor of heparin-binding EGF-like growth factor, in human resistant ovarian cancer. Biochem. Biophys. Res. Commun. 422:676-680. http://dx.doi.org/10.1016/j.bbrc.2012.05.052
86. Tokumaru, S., S. Higashiyama, T. Endo, T. Nakagawa, J.I. Miyagawa, K. Yamamori, Y. Hanakawa, H. Ohmoto, K. Yoshino, Y. Shirakata, et al. 2000. Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing. J. Cell Biol. 151:209-220. http://dx.doi.org/10.1083/jcb.151.2.209
87. Vaupel, P., K. Schlenger, C. Knoop, and M. Höckel. 1991. Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res. 51:3316-3322.
88. Wachi, S., K. Yoneda, and R. Wu. 2005. Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues. Bioinformatics. 21:4205-4208. http://dx.doi.org/10.1093/bioinformatics/bti688
89. Wang, F., C. Sloss, X. Zhang, S.W. Lee, and J.C. Cusack. 2007. Membranebound heparin-binding epidermal growth factor like growth factor regulates E-cadherin expression in pancreatic carcinoma cells. Cancer Res. 67:8486-8493. http://dx.doi.org/10.1158/0008-5472.CAN-07-0498
90. Wang, G.L., B.H. Jiang, E.A. Rue, and G.L. Semenza. 1995. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA. 92:5510-5514. http://dx.doi.org/10.1073/pnas.92.12.5510
91. Wang, N.J., Z. Sanborn, K.L. Arnett, L.J. Bayston, W. Liao, C.M. Proby, I.M. Leigh, E.A. Collisson, P.B. Gordon, L. Jakkula, et al. 2011. Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc. Natl. Acad. Sci. USA. 108:17761-17766. http://dx.doi.org/10.1073/pnas.1114669108
92. Weaver, A.M. 2006. Invadopodia: specialized cell structures for cancer invasion. Clin. Exp. Metastasis. 23:97-105. http://dx.doi.org/10.1007/s10585-006-9014-1
93. Weng, A.P., A.A. Ferrando, W. Lee, J.P. Morris IV, L.B. Silverman, C. Sanchez-Irizarry, S.C. Blacklow, A.T. Look, and J.C. Aster. 2004. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 306:269-271. http://dx.doi.org/10.1126/science.1102160
94. Wharton, K.A., K.M. Johansen, T. Xu, and S. Artavanis-Tsakonas. 1985. Nucleotide sequence from the neurogenic locus notch implies a gene product that shares homology with proteins containing EGF-like repeats. Cell. 43:567-581. http://dx.doi.org/10.1016/0092-8674(85)90229-6
95. Xing, F., H. Okuda, M. Watabe, A. Kobayashi, S.K. Pai, W. Liu, P.R. Pandey, K. Fukuda, S. Hirota, T. Sugai, et al. 2011. Hypoxia-induced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cells. Oncogene. 30:4075-4086. http://dx.doi.org/10.1038/onc.2011.122
96. Xu, K.P., Y. Ding, J. Ling, Z. Dong, and F.S. Yu. 2004. Wound-induced HBEGF ectodomain shedding and EGFR activation in corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 45:813-820. http://dx.doi.org/10.1167/iovs.03-0851
97. Yamada, D., K. Ohuchida, K. Mizumoto, S. Ohhashi, J. Yu, T. Egami, H. Fujita, E. Nagai, and M. Tanaka. 2007. Increased expression of ADAM 9 and ADAM 15 mRNA in pancreatic cancer. Anticancer Res. 27:793-799.
98. Yamaguchi, H., M. Lorenz, S. Kempiak, C. Sarmiento, S. Coniglio, M. Symons, J. Segall, R. Eddy, H. Miki, T. Takenawa, and J. Condeelis. 2005. Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin. J. Cell Biol. 168:441-452. http://dx.doi.org/10.1083/jcb.200407076
99. Yang, Y., Y.H. Ahn, D.L. Gibbons, Y. Zang, W. Lin, N. Thilaganathan, C.A. Alvarez, D.C. Moreira, C.J. Creighton, P.A. Gregory, et al. 2011. The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice. J. Clin. Invest. 121:1373-1385. http://dx.doi.org/10.1172/JCI42579
100. Young, S.D., R.S. Marshall, and R.P. Hill. 1988. Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc. Natl. Acad. Sci. USA. 85:9533-9537. http://dx.doi.org/10.1073/pnas.85.24.9533
101. Zavadil, J., L. Cermak, N. Soto-Nieves, and E.P. Böttinger. 2004. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J. 23:1155-1165. http://dx.doi.org/10.1038/sj.emboj.7600069
102. Zeng, Q., S. Li, D.B. Chepeha, T.J. Giordano, J. Li, H. Zhang, P.J. Polverini, J. Nor, J. Kitajewski, and C.Y. Wang. 2005. Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. Cancer Cell. 8:13-23. http://dx.doi.org/10.1016/j.ccr.2005.06.004